Gold-level Stevie® Award recognizes Maetzold’s transformative leadership in the healthcare industry, including molecular ...

Sagimet Biosciences Inc. (NASDAQ:SGMT) saw its stock soar 20% after unveiling encouraging Phase 3 trial results for its acne ...

Regencell's stock soared 17,000% fueled by speculation, despite no revenue or clinical progress. Read why I think the RGC ...

By bolstering immune cells, researchers at ViiV Healthcare in Branford have designed long-acting drugs that prevent infection ...

The company hopes to submit its lead drug later this year for FDA approval. What these 3 Bay Area biotech companies did to ...

Shares of Cellectar Biosciences Inc (NASDAQ:CLRB) surged 63.5% following the announcement that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for its cancer ...

Shares of Sagimet Biosciences rose after the company disclosed what it called positive results from a recent clinical trial of its treatment for moderate-to-severe acne. The stock jumped 42%, to $5.20 ...

Epidermolysis bullosa is a rare and severe skin disease where patients have fragile skin that blisters and tears. A Mt.

The Holliston, Massachusetts-based company said it had a loss of $1.14 per share. Losses, adjusted for one-time gains and costs, were 1 cent per share. While Harvard Bioscience, Inc. ( NASDAQ ...

IO Biotech ( ($IOBT) ) has issued an update. IO Biotech, Inc. faced a compliance issue with Nasdaq’s minimum bid price requirement when its stock ...

Colossal Biosciences is a trailblazing company that's pushing the boundaries of genetic engineering and shattering them.

For investors still seeking companiies with attractive long-term prospects, let's consider two in the biotech industry: ...